The circadian rhythm of corticosteroid-binding globulin has little impact on cortisol exposure after hydrocortisone dosing.

Johanna Melin, Niklas Hartung, Zinnia P Parra-Guillen, Martin J Whitaker, Richard J Ross, Charlotte Kloft

Journal: Clinical endocrinology 2020;91(1):33-40

PMID: 30868607

Abstract

CONTEXT

Optimization of hydrocortisone replacement therapy is important to prevent under- and over dosing. Hydrocortisone pharmacokinetics is complex as circulating cortisol is protein bound mainly to corticosteroid-binding globulin (CBG) that has a circadian rhythm.

OBJECTIVE

A detailed analysis of the CBG circadian rhythm and its impact on cortisol exposure after hydrocortisone administration.

DESIGN AND METHODS

CBG was measured over 24 hours in 14 healthy individuals and, employing a modelling and simulation approach using a semi-mechanistic hydrocortisone pharmacokinetic model, we evaluated the impact on cortisol exposure (area under concentration-time curve and maximum concentration of total cortisol) of hydrocortisone administration at different clock times and of the changing CBG concentrations.

RESULTS

The circadian rhythm of CBG was well described with two cosine terms added to the baseline of CBG: baseline CBG was 21.8 µg/mL and interindividual variability 11.9%; the amplitude for the 24 and 12 hours cosine functions were relatively small (24 hours: 5.53%, 12 hours: 2.87%) and highest and lowest CBG were measured at 18:00 and 02:00, respectively. In simulations, the lowest cortisol exposure was observed after administration of hydrocortisone at 23:00-02:00, whereas the highest was observed at 15:00-18:00. The differences between the highest and lowest exposure were minor (≤12.2%), also regarding the free cortisol concentration and free fraction (≤11.7%).

CONCLUSIONS

Corticosteroid-binding globulin has a circadian rhythm but the difference in cortisol exposure is ≤12.2% between times of highest and lowest CBG concentrations; therefore, hydrocortisone dose adjustment based on time of dosing to adjust for the CBG concentrations is unlikely to be of clinical benefit.

© 2019 John Wiley & Sons Ltd.

Address: Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Berlin, Germany.; Graduate Research Training Program, PharMetrX, Berlin, Germany.; Institute of Mathematics, University of Potsdam, Potsdam, Germany.; Department of Pharmacy and Pharmaceutical Technology, Pharmacometrics and Systems Pharmacology, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.; Diurnal Limited, Cardiff, UK.; University of Sheffield, Sheffield, UK.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.